How does the neuronal MPS affect Alzheimer’s risk?
New role for a neuronal ‘gatekeeper’ alters protein traffic
Researchers have identified a previously underappreciated function of the neuronal membrane periodic skeleton (MPS): it regulates how neurons take up nutrients and other cargo. The MPS sits under the cell membrane in neurons and acts like a structural scaffold. When intact, it appears to slow certain forms of endocytosis — the process by which cells draw material inward — helping to maintain balanced trafficking of proteins and lipids inside nerve cells.
Laboratory work shows that when the MPS is disrupted, endocytosis accelerates. Faster or dysregulated uptake changes intracellular sorting and clearance pathways and creates cellular conditions that favor accumulation of amyloidogenic proteins. In experimental systems this shift correlates with increased buildup of toxic amyloid species linked to Alzheimer’s disease.
Why this matters
- The finding links a structural, mechanical feature of neurons to molecular events long associated with neurodegeneration.
- It identifies the MPS as a potential upstream contributor to pathogenic protein accumulation, rather than a passive bystander.
- Targeting the processes that preserve MPS integrity, or normalizing the altered endocytic traffic that follows MPS disruption, opens new therapeutic avenues distinct from approaches that only try to remove amyloid after it forms.
The results do not yet resolve all questions. It remains unclear how early in disease progression MPS changes occur in people, and whether preserving the MPS can reverse established pathology. Still, the discovery reframes part of Alzheimer’s biology by connecting cellular architecture to the nutrient‑ and cargo‑handling systems that can steer neurons toward health or toxicity. That link gives researchers a new, more physical target to study in the search for interventions that slow or prevent Alzheimer’s-related protein buildup.